Abstract:Ondansetron tablets that are directly compressed using crospovidone and croscarmellose as a synthetic super disintegrant are the subject of this investigation. A central composite, response surface, randomly quadratic, nonblock (version 13.0.9.0) 32 factorial design is used to optimize the formulation (two-factor three-level). To make things even more complicated, nine different formulation batches (designated as F1–F9) were created. There were three levels of crospovidone and croscarmellose (+1, 0, -1). In addition to that, pre- and postcompressional parameters were evaluated, and all evaluated parameters were found to be within acceptable range. Among all postcompressional parameter dispersion and disintegration time, in vitro drug release experiments (to quantify the amount of medication released from the tablet) and their percentage prediction error were shown to have a significant influence on three dependent variables. Various pre- and postcompression characteristics of each active component were tested in vitro. Bulk density, tap density, angle of repose, Carr's index, and the Hausner ratio were all included in this analysis, as were many others. This tablet's hardness and friability were also assessed along with its dimension and weight variations. Additional stability studies may be conducted using the best batch of the product. For this study, we utilised the Design-Expert software to select the formulation F6, which had dispersion times of 17.67 ± 0.03 seconds, disintegration times of 120.12 ± 0.55 seconds, and percentage drug release measurements of 99.25 ± 0.36 within 30 minutes. Predicted values and experimental data had a strong correlation. Fast dissolving pills of ondansetron hydrochloride may be created by compressing the tablets directly.

Study on the Formulation Optimization and Dissolution of Yinzhihuang Dispersible Tablets

Preparation and Quality Control of Levamlodipine Besylate Orally Disintegrating Tablets

On Formula Optimization for Valaciclovir Dispersible Tablets

Preparetion of Ketanning Dispersible Tablet

Preparation and Optimization of the Formulation of Flupirtine Maleate Orally Disintegrating Tablets

Preparation of Helicid Orally Disintegrating Tablets

Preparation of Weitengnin Dispersible Tablets

Study on the Preparation Technique of Tanshinone Dispersible Tablets

Optimization of formulation for the Qiyuejiangzhi tablets

Study of Hot Melt Granulation to Improve Dissolution Rate of Empagliflozin

Investigating the effects of formulation variables on the disintegration of spray dried amorphous solid dispersion tablets

Study on the New Processing Procedure and Quality Control for Multi-vitamins and Electrolytes Effervescent Tablets

Preparation of Ondansetron Hydrochloride Orally Disintegrating Tablets

Preparation and In Vitro Evaluation of Solid Dispersions of Total Flavones of Hippophae rhamnoides L.

Optimized Formulation of Rizatriptan Benzoate Tablet by a Central Composite Design/Response Surface Methodology

Optimization of Cudrania Extractum Tablets Formulation by Central Composite Design-Response Surface Methodology

A novel and discriminative method of in vitro disintegration time for preparation and optimization of taste-masked orally disintegrating tablets of carbinoxamine maleate

Central Composite Designed Fast Dissolving Tablets for Improved Solubility of the Loaded Drug Ondansetron Hydrochloride

Study on the formulation of Xiaomi Vagina Effervescent Tablets

[Self-inflating cuff--experiments in dogs].

Optimization of preparation technique for the Qiyuejiangzhi tablets